Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Promising renoprotective effect of gold nanoparticles and dapagliflozin in diabetic nephropathy via targeting miR-192 and miR-21
Mihm, M
16 January 2013
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
Yang, R., Dong, S., Zhang, J., Zhu, S., Miao, G., & Zhang, B
Licensed Peptides provides research-grade Cagrilintide to U.S.-based laboratories operating under appropriate regulatory frameworks
US$ 21.16
US$ 28.79
US$ 29.32
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ff27%2Fb3a%2F460%2Ff27b3a460e92bcdc8635b6aa1b0eff12.jpg)
US$ 28.52
